Renin-angiotensin system hyperactivation can induce inflammation and retinal neural dysfunction

International Journal of Inflammation

Volumn 2012, Issue , 2012, Pages

  Kurihara, Toshihide ^a,b   Ozawa, Yoko ^a   Ishida, Susumu ^a,c   Okano, Hideyuki ^a   Tsubota, Kazuo ^a  

^a KEIO UNIVERSITY   (Japan)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALISKIREN; ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; PLACEBO; SYNAPTOPHYSIN; VASCULOTROPIN INHIBITOR;

BLOOD BRAIN BARRIER; BLOOD PRESSURE REGULATION; CHRONIC INFLAMMATION; DIABETIC RETINOPATHY; DRUG EFFICACY; DRUG RESEARCH; ENDOCRINE DISEASE; EXUDATIVE MACULAR DEGENERATION; EYE DISEASE; EYE INFLAMMATION; GENETIC POLYMORPHISM; GLAUCOMA; HUMAN; HYPERTENSION; INTRAOCULAR HYPERTENSION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENIN ANGIOTENSIN SYSTEM HYPERACTIVATION; RETINA DISEASE; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEURAL DYSFUNCTION; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; UVEITIS;

EID: 84873339360     PISSN: 20908040     EISSN: 20420099     Source Type: Journal    
DOI: 10.1155/2012/581695     Document Type: Review

References (200)

1. Klein R., Klein B. E. K., Linton K. L. P., Prevalence of age-related maculopathy: the Beaver Dam Eye study. Ophthalmology 1992 99 6 933 943 2-s2.0-0026681119
2. Tielsch J. M., Sommer A., Katz J., Royall R. M., Quigley H. A., Javitt J., Racial variations in the prevalence of primary open-angle glaucoma: the Baltimore eye survey. Journal of the American Medical Association 1991 266 3 369 374 2-s2.0-0025916983 10.1001/jama.266.3.369
3. Davis M. D., Fisher M. R., Gangnon R. E., Barton F., Aiello L. M., Chew E. Y., Ferris F. L., Knatterud G. L., Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: early treatment diabetic retinopathy study report 18. Investigative Ophthalmology and Visual Science 1998 39 2 233 252 2-s2.0-0031917205 (Pubitemid 28093859)
4. Haigis M. C., Yankner B. A., The Aging Stress Response. Molecular Cell 2010 40 2 333 344 2-s2.0-78649350746 10.1016/j.molcel.2010.10.002
5. Glass C. K., Saijo K., Winner B., Marchetto M. C., Gage F. H., Mechanisms Underlying Inflammation in Neurodegeneration. Cell 2010 140 6 918 934 2-s2.0-77950363010 10.1016/j.cell.2010.02.016
6. Balaban R. S., Nemoto S., Finkel T., Mitochondria, oxidants, and aging. Cell 2005 120 4 483 495 2-s2.0-13944278132 10.1016/j.cell.2005.02.001 (Pubitemid 40269763)
7. Salzet M., Deloffre L., Breton C., Vieau D., Schoofs L., The angiotensin system elements in invertebrates. Brain Research Reviews 2001 36 1 35 45 2-s2.0-0034893081 10.1016/S0165-0173(01)00063-7 (Pubitemid 32763128)
8. Kurihara T., Ozawa Y., Shinoda K., Nagai N., Inoue M., Oike Y., Tsubota K., Ishida S., Okano H., Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation. Investigative Ophthalmology and Visual Science 2006 47 12 5545 5552 2-s2.0-34248174851 10.1167/iovs.06-0478 (Pubitemid 46723808)
9. Kurihara T., Ozawa Y., Nagai N., Shinoda K., Noda K., Imamura Y., Tsubota K., Okano H., Oike Y., Ishida S., Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina. Diabetes 2008 57 8 2191 2198 2-s2.0-50949116171 10.2337/db07-1281
10. Chen P., Scicli G. M., Guo M., Fenstermacher J. D., Dahl D., Edwards P. A., Guillermo Scicli A., Role of angiotensin II in retinal leukostasis in the diabetic rat. Experimental Eye Research 2006 83 5 1041 1051 2-s2.0-33748705959 10.1016/j.exer.2006.05.009 (Pubitemid 44397025)
11. Miller A. G., Tan G., Binger K. J., Pickering R. J., Thomas M. C., Nagaraj R. H., Cooper M. E., Wilkinson-Berka J. L., Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function. Diabetes 2010 59 12 3208 3215 2-s2.0-78650044928 10.2337/db10-0552
12. Miyazaki A., Kitaichi N., Ohgami K., Iwata D., Jin X. H., Iwabuchi K., Morohashi T., Ohno S., Onoé K., Anti-inflammatory effect of angiotensin type 1 receptor antagonist on endotoxin-induced uveitis in rats. Graefe's Archive for Clinical and Experimental Ophthalmology 2008 246 5 747 757 2-s2.0-42049120493 10.1007/s00417-007-0730-2
13. Mori F., Hikichi T., Nagaoka T., Takahashi J., Kitaya N., Yoshida A., Inhibitory effect of losartan, an AT1 angiotensin II receptor antagonist, on increased leucocyte entrapment in retinal microcirculation of diabetic rats. British Journal of Ophthalmology 2002 86 10 1172 1174 2-s2.0-0036785429 10.1136/bjo.86.10.1172
14. Nagai N., Izumi-Nagai K., Oike Y., Koto T., Satofuka S., Ozawa Y., Yamashiro K., Inoue M., Tsubota K., Umezawa K., Ishida S., Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor- κ B pathway. Investigative Ophthalmology and Visual Science 2007 48 9 4342 4350 2-s2.0-35148898712 10.1167/iovs.06-1473 (Pubitemid 351261068)
15. Nagai N., Noda K., Urano T., Kubota Y., Shinoda H., Koto T., Shinoda K., Inoue M., Shiomi T., Ikeda E., Tsubota K., Suda T., Oike Y., Ishida S., Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor. Investigative Ophthalmology and Visual Science 2005 46 3 1078 1084 2-s2.0-20144389813 10.1167/iovs.04-1101 (Pubitemid 41321048)
16. Nagai N., Oike Y., Izumi-Nagai K., Urano T., Kubota Y., Noda K., Ozawa Y., Inoue M., Tsubota K., Suda T., Ishida S., Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 10 2252 2259 2-s2.0-33749045058 10.1161/01.ATV.0000240050.15321.fe (Pubitemid 44465719)
17. Nagai N., Oike Y., Noda K., Urano T., Kubota Y., Ozawa Y., Shinoda H., Koto T., Shinoda K., Inoue M., Tsubota K., Yamashiro K., Suda T., Ishida S., Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor. Investigative Ophthalmology and Visual Science 2005 46 8 2925 2931 2-s2.0-24644446540 10.1167/iovs.04-1476 (Pubitemid 43086715)
18. Okunuki Y., Usui Y., Nagai N., Kezuka T., Ishida S., Takeuchi M., Goto H., Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan. Investigative Ophthalmology and Visual Science 2009 50 5 2255 2261 2-s2.0-65549151327 10.1167/iovs.08-2649
19. Wilkinson-Berka J. L., Tan G., Jaworski K., Ninkovic S., Valsartan but not Atenolol Improves Vascular Pathology in Diabetic Ren-2 Rat Retina. American Journal of Hypertension 2007 20 4 423 430 2-s2.0-33947326902 10.1016/j.amjhyper.2006.09.018 (Pubitemid 46441750)
20. Downie L. E., Hatzopoulos K. M., Pianta M. J., Vingrys A. J., Wilkinson-Berka J. L., Kalloniatis M., Fletcher E. L., Angiotensin type-1 receptor inhibition is neuroprotective to amacrine cells in a rat model of retinopathy of prematurity. Journal of Comparative Neurology 2010 518 1 41 63 2-s2.0-74049085007 10.1002/cne.22205
21. Fukuda K., Hirooka K., Mizote M., Nakamura T., Itano T., Shiraga F., Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor. Investigative Ophthalmology & Visual Science 2010 51 7 3629 3638 2-s2.0-77955884119
22. Silva K. C., Rosales M. A. B., Biswas S. K., De Faria J. B. L., De Faria J. M. L., Diabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetes. Diabetes 2009 58 6 1382 1390 2-s2.0-66649114798 10.2337/db09-0166
23. Yang H., Hirooka K., Fukuda K., Shiraga F., Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma. Investigative Ophthalmology & Visual Science 2009 50 12 5800 5804 2-s2.0-73349132037
24. Chaturvedi N., Porta M., Klein R., Orchard T., Fuller J., Parving H. H., Bilous R., Sjolie A. K., Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials. The Lancet 2008 372 9647 1394 1402 2-s2.0-53749100124 10.1016/S0140-6736(08)61412-9
25. Sjolie A. K., Klein R., Porta M., Orchard T., Fuller J., Parving H. H., Bilous R., Chaturvedi N., Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. The Lancet 2008 372 9647 1385 1393 2-s2.0-53749108177 10.1016/S0140-6736(08)61411-7
26. Mauer M., Zinman B., Gardiner R., Suissa S., Sinaiko A., Strand T., Drummond K., Donnelly S., Goodyer P., Gubler M. C., Klein R., Renal and retinal effects of enalapril and losartan in type 1 diabetes. New England Journal of Medicine 2009 361 1 40 51 2-s2.0-67649635807 10.1056/NEJMoa0808400
27. Goldblatt H., Lynch J., Hanzal R. F., Summerville W. W., Studies on experimental hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. The Journal of Experimental Medicine 1934 59 3 347 379
28. Fasciolo J. C., Houssay B. A., Taquini A. C., The blood-pressure raising secretion of the ischaemic kidney. The Journal of Physiology 1938 94 3 281 293
29. Page I. H., On the nature of the pressor action of renin. The Journal of Experimental Medicine 1939 70 5 521 542
30. Braun-Menendez E., Page I. H., Suggested revision of nomenclatureangiotensin. Science 1958 127 3292 242 2-s2.0-0000049489
31. Skeggs L. T. Jr, Kahn J. R., Shumway N. P., The preparation and function of the hypertensin-converting enzyme. The Journal of Experimental Medicine 1956 103 3 295 299
32. Lin S. Y., Goodfriend T. L., Angiotensin receptors. The American journal of physiology 1970 218 5 1319 1328 2-s2.0-0014781009
33. Sarlos S., Rizkalla B., Moravski C. J., Cao Z., Cooper M. E., Wilkinson-Berka J. L., Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin. American Journal of Pathology 2003 163 3 879 887 2-s2.0-0041924832 (Pubitemid 37040124)
34. 2R expression and subsequent vulnerability to adult ischaemic injury. Cardiovascular Research 2011 89 2 300 308 10.1093/cvr/cvq303
35. Sasaki K., Yamano Y., Bardhan S., Iwai N., Murray J. J., Hasegawa M., Matsuda Y., Inagami T., Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature 1991 351 6323 230 233 2-s2.0-0025756064 10.1038/351230a0 (Pubitemid 21896570)
36. Murphy T. J., Alexander R. W., Griendling K. K., Runge M. S., Bernstein K. E., Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 1991 351 6323 233 236 2-s2.0-0025758883 10.1038/351233a0 (Pubitemid 21896571)
37. Ushio-Fukai M., Griendling K. K., Akers M., Lyons P. R., Alexander R. W., Temporal dispersion of activation of phospholipase C- β 1 and-γ isoforms by angiotensin II in vascular smooth muscle cells. Role of α q/11, α 12, and βγ G protein subunits. The Journal of Biological Chemistry 1998 273 31 19772 19777 (Pubitemid 28367037)
38. Anderson J. M., Gimbrone M. A., Alexander R. W., Angiotensin II stimulates phosphorylation of the myosin light chain in cultured vascular smooth muscle cells. Journal of Biological Chemistry 1981 256 10 4693 4696 2-s2.0-0019863154 (Pubitemid 11035323)
39. Dostal D. E., Murahashi T., Peach M. J., Regulation of cytosolic calcium by angiotensins in vascular smooth muscle. Hypertension 1990 15 6 815 822 2-s2.0-0025362799 (Pubitemid 20189464)
40. Soubrier F., Alhenc-Gelas F., Hubert C., Allegrini J., John M., Tregear G., Corvol P., Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proceedings of the National Academy of Sciences of the United States of America 1988 85 24 9386 9390 2-s2.0-0000110931 (Pubitemid 19027137)
41. Dell'Italia L. J., Meng Q. C., Balcells E., Wei C. C., Palmer R., Hageman G. R., Durand J., Hankes G. H., Oparil S., Compartmentalization of angiotensin II generation in the dog heart: evidence for independent mechanisms in intravascular and interstitial spaces. Journal of Clinical Investigation 1997 100 2 253 258 2-s2.0-0030838414 (Pubitemid 27349070)
42. Kimbrough H. M., Vaughan E. D., Carey R. M., Ayers C. R., Effect of intrarenal angiotensin II blockade on renal function in conscious dogs. Circulation Research 1977 40 2 174 178 2-s2.0-0017359613 (Pubitemid 8043438)
43. Ryan J. W., Renin-like enzyme in the adrenal gland. Science 1967 158 3808 1589 1590 2-s2.0-0014214352
44. Ganten D., Minnich J. L., Granger P., Hayduk K., Brecht H. M., Barblau A., Boucher R., Genest J., Angiotensin-forming enzyme in brain tissue. Science 1971 173 3991 64 65 2-s2.0-0015208111
45. Ichihara A., Hayashi M., Kaneshiro Y., Suzuki F., Nakagawa T., Tada Y., Koura Y., Nishiyama A., Okada H., Uddin M. N., Nabi A. H. M. N., Ishida Y., Inagami T., Saruta T., Inhibition of diabetic nephropathy by a decoy peptide corresponding to the 'handle' region for nonproteolytic activation of prorenin. Journal of Clinical Investigation 2004 114 8 1128 1135 2-s2.0-9644283069 10.1172/JCI200421398 (Pubitemid 39578702)
46. Nguyen G., Delarue F., Burcklé C., Bouzhir L., Giller T., Sraer J. D., Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. Journal of Clinical Investigation 2002 109 11 1417 1427 2-s2.0-0036266596 10.1172/JCI200214276 (Pubitemid 34596167)
47. Cruciat C. M., Ohkawara B., Acebron S. P., Karaulanov E., Reinhard C., Ingelfinger D., Boutros M., Niehrs C., Requirement of prorenin receptor and vacuolar H+-ATPase-mediated acidification for Wnt signaling. Science 2010 327 5964 459 463 2-s2.0-75649120756 10.1126/science.1179802
48. Marrero M. B., Schieffer B., Paxton W. G., Heerdt L., Berk B. C., Delafontaine P., Bernstein K. E., Direct stimulation of Jak/STAT pathway by the anglotensin II AT1 receptor. Nature 1995 375 6528 247 250 2-s2.0-0029019246
49. Schieffer B., Luchtefeld M., Braun S., Hilfiker A., Hilfiker-Kleiner D., Drexler H., Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction. Circulation Research 2000 87 12 1195 1201 2-s2.0-0034623784
50. Kim S., Izumi Y., Yano M., Hamaguchi A., Miura K., Yamanaka S., Miyazaki H., Iwao H., Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery. Circulation 1998 97 17 1731 1737 2-s2.0-0032485849 (Pubitemid 28211423)
51. Liao D. F., Duff J. L., Daum G., Pelech S. L., Berk B. C., Angiotensin II stimulates MAP kinase kinase kinase activity in vascular smooth muscle cells: role of raf. Circulation Research 1996 79 5 1007 1014 2-s2.0-0029861478 (Pubitemid 26359241)
52. Liao D. F., Monia B., Dean N., Berk B. C., Protein kinase C- ζ mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells. Journal of Biological Chemistry 1997 272 10 6146 6150 2-s2.0-0030892639 10.1074/jbc.272.10.6146 (Pubitemid 27118081)
53. Nishida M., Tanabe S., Maruyama Y., Mangmool S., Urayama K., Nagamatsu Y., Takagahara S., Turner J. H., Kozasa T., Kobayashi H., Sato Y., Kawanishi T., Inoue R., Nagao T., Kurose H., G α 12/13- and reactive oxygen species-dependent activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase by angiotensin receptor stimulation in rat neonatal cardiomyocytes. Journal of Biological Chemistry 2005 280 18 18434 18441 2-s2.0-20744448925 10.1074/jbc.M409710200 (Pubitemid 41389093)
54. Rajagopalan S., Kurz S., Münzel T., Tarpey M., Freeman B. A., Griendling K. K., Harrison D. G., Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. Journal of Clinical Investigation 1996 97 8 1916 1923 2-s2.0-0030005713
55. Touyz R. M., Chen X., Tabet F., Yao G., He G., Quinn M. T., Pagano P. J., Schiffrin E. L., Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circulation Research 2002 90 11 1205 1213 2-s2.0-0037076798 10.1161/01.RES.0000020404.01971.2F (Pubitemid 34786906)
56. Griendling K. K., Minieri C. A., Ollerenshaw J. D., Alexander R. W., Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circulation Research 1994 74 6 1141 1148 2-s2.0-0028365310 (Pubitemid 24176909)
57. Seshiah P. N., Weber D. S., Rocic P., Valppu L., Taniyama Y., Griendling K. K., Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circulation Research 2002 91 5 406 413 2-s2.0-0037032024 10.1161/01.RES.0000033523.08033.16 (Pubitemid 35034208)
58. Moriguchi Y., Matsubara H., Mori Y., Murasawa S., Masaki H., Maruyama K., Tsutsumi Y., Shibasaki Y., Tanaka Y., Nakajima T., Oda K., Iwasaka T., Angiotensin II-induced transactivation of epidermal growth factor receptor regulates fibronectin and transforming growth factor- β synthesis via transcriptional and posttranscriptional mechanisms. Circulation Research 1999 84 9 1073 1084 2-s2.0-0033553523 (Pubitemid 29227687)
59. Kagiyama S., Eguchi S., Frank G. D., Inagami T., Zhang Y. C., Phillips M. I., Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense. Circulation 2002 106 8 909 912 2-s2.0-0037143616 10.1161/01.CIR.0000030181.63741.56 (Pubitemid 34925322)
60. Muller D. N., Dechend R., Mervaala E. M. A., Park J. K., Schmidt F., Fiebeler A., Theuer J., Breu V., Ganten D., Haller H., Luft F. C., NF- κ B inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension 2000 35 1 193 201 2-s2.0-0033630346 (Pubitemid 30054172)
61. Fiebeler A., Schmidt F., Müller D. N., Park J. K., Dechend R., Bieringer M., Shagdarsuren E., Breu V., Haller H., Luft F. C., Mineralocorticoid receptor affects AP-1 and nuclear factor- κ B activation in angiotensin II-induced cardiac injury. Hypertension 2001 37 2 787 793 2-s2.0-0035090207 (Pubitemid 32199067)
62. Hernández-Presa M., Bustos C., Ortego M., Tuñon J., Renedo G., Ruiz-Ortega M., Egido J., Angiotensin-converting enzyme inhibition prevents arterial nuclear factor- κ B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 1997 95 6 1532 1541 2-s2.0-0030950540 (Pubitemid 27142812)
63. Kudoh S., Komuro I., Mizuno T., Yamazaki T., Zou Y., Shiojima I., Takekoshi N., Yazaki Y., Angiotensin II stimulates c-jun NH2-terminal kinase in cultured cardiac myocytes of neonatal rats. Circulation Research 1997 80 1 139 146 2-s2.0-0031015356 (Pubitemid 27030378)
64. Puri P. L., Avantaggiati M. L., Burgio V. L., Chirillo P., Collepardo D., Natoli G., Balsano C., Levrero M., Reactive oxygen intermediates mediate angiotensin II-induced c-Jun·c-Fos heterodimer DNA binding activity and proliferative hypertrophic responses in myogenic cells. Journal of Biological Chemistry 1995 270 38 22129 22134 2-s2.0-0029086511 10.1074/jbc.270.38.22129
65. Vaughan D. E., Lazos S. A., Tong K., Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis. Journal of Clinical Investigation 1995 95 3 995 1001 2-s2.0-0028912882
66. Daugherty A., Manning M. W., Cassis L. A., Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. Journal of Clinical Investigation 2000 105 11 1605 1612 2-s2.0-0034129997 (Pubitemid 30390311)
67. Ondetti M. A., Rubin B., Cushman D. W., Design of specific inhibitors of angiotensin converting enzyme: new class of orally active antihypertensive agents. Science 1977 196 4288 441 444 2-s2.0-0017578611 (Pubitemid 8073845)
68. Timmermans P. B. M. W. M., Carini D. J., Chiu A. T., Duncia J. V., Price W. A., Wells G. J., Wong P. C., Wexler R. R., Johnson A. L., Angiotensin II receptor antagonists: from discovery to antihypertensive drugs. Hypertension 1991 18 5 I-136 I-142 2-s2.0-0026004798
69. Wong P. C., Price W. A., Chiu A. T., Carini D. J., Duncia J. V., Johnson A. L., Wexler R. R., Timmermans P. B. M. W. M., Nonpeptide angiotensin II receptor antagonists. Studies with EXP9270 and DuP 753. Hypertension 1990 15 6 823 834 2-s2.0-0025370619 (Pubitemid 20189465)
70. Green D. R., Galluzzi L., Kroemer G., Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science 2011 333 6046 1109 1112 10.1126/science.1201940
71. Baiardi G., Bregonzio C., Jezova M., Armando I., Saavedra J. M., Angiotensin II AT1 receptor blockade prolongs the lifespan of spontaneously hypertensive rats and reduces stress-induced release of catecholamines, glucocorticoids, and vasopressin. Annals of the New York Academy of Sciences 2004 1018 131 136 2-s2.0-3242706725 10.1196/annals.1296.015 (Pubitemid 38951399)
72. Linz W., Heitsch H., Schölkens B. A., Wiemer G., Long-term angiotensin II type 1 receptor blockade with fonsartan doubles lifespan of hypertensive rats. Hypertension 2000 35 4 908 913 2-s2.0-0034106595 (Pubitemid 30303949)
73. Linz W., Jessen T., Becker R. H. A., Schölkens B. A., Wiemer G., Long-term ACE inhibition doubles lifespan of hypertensive rats. Circulation 1997 96 9 3164 3172 2-s2.0-0030699961 (Pubitemid 27500122)
74. Benigni A., Corna D., Zoja C., Sonzogni A., Latini R., Salio M., Conti S., Rottoli D., Longaretti L., Cassis P., Morigi M., Coffman T. M., Remuzzi G., Disruption of the Ang II type 1 receptor promotes longevity in mice. Journal of Clinical Investigation 2009 119 3 524 530 2-s2.0-65349128571 10.1172/JCI36703
75. Mendelsohn F. A., Quirion R., Saavedra J. M., Aguilera G., Catt K. J., Autoradiographic localization of angiotensin II receptors in rat brain. Proceedings of the National Academy of Sciences of the United States of America 1984 81 5 1575 1579 2-s2.0-0021396557 (Pubitemid 14174546)
76. Saavedra J. M., Correa F. M.A., Plunkett L. M., Binding of angiotensin and atrial natriuretic peptide in brain of hypertensive rats. Nature 1986 320 6064 758 760 (Pubitemid 16066792)
77. Buggy J., Fisher A. E., Hoffman W. E., Ventricular obstruction: effect on drinking induced by intracranial injection of angiotensin. Science 1975 190 4209 72 74 2-s2.0-0016711292
78. Van Houten M., Schiffrin E. L., Mann J. F. E., Radioautographic localization of specific binding sites for blood-borne angiotensin II in the rat brain. Brain Research 1980 186 2 480 485 2-s2.0-0018887146 10.1016/0006- 8993(80)90995-6 (Pubitemid 10109531)
79. Castren R., Saavedra J. M., Angiotensin II receptors in paraventricular nucleus, subfornical organ, and pituitary gland of hypophysectomized, adrenalectomized, and vasopressin-deficient rats. Proceedings of the National Academy of Sciences of the United States of America 1989 86 2 725 729 2-s2.0-0024543432 (Pubitemid 19037814)
80. Chevillard C., Saavedra J. M., High angiotensin-converting enzyme activity in the neurohypophysis of Brattleboro rats. Science 1982 216 4546 646 647 2-s2.0-0020471921 (Pubitemid 12098067)
81. Landas S., Phillips M. I., Stamler J. F., Raizada M. K., Visualization of specific angiotensin II binding sites in the brain by fluorescent microscopy. Science 1980 210 4471 791 793 2-s2.0-0019140858 (Pubitemid 11203240)
82. Zimmerman M. C., Lazartigues E., Lang J. A., Sinnayah P., Ahmad I. M., Spitz D. R., Davisson R. L., Superoxide mediates the actions of angiotensin II in the central nervous system. Circulation Research 2002 91 11 1038 1045 2-s2.0-0037195696 10.1161/01.RES.0000043501.47934.FA (Pubitemid 35416641)
83. Danser A. H. J., Van Den Dorpel M. A., Deinum J., Derkx F. H. M., Franken A. A. M., Peperkamp E., De Jong P. T. V. M., Schalekamp M. A. D. H., Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy. Journal of Clinical Endocrinology and Metabolism 1989 68 1 160 167 2-s2.0-0024495446 (Pubitemid 19028740)
84. Deinum J., Derkx F. H. M., Danser A. H. J., Schalekamp M. A. D. H., Identification and quantification of renin and prorenin in the bovine eye. Endocrinology 1990 126 3 1673 1682 2-s2.0-0025215192 (Pubitemid 20095779)
85. Sramek S. J., Wallow I. H. L., Day R. P., Ehrlich E. N., Ocular renin-angiotensin: immunohistochemical evidence for the presence of prorenin in eye tissue. Investigative Ophthalmology and Visual Science 1988 29 11 1749 1752 2-s2.0-0023775822
86. Berka J. L., Stubbs A. J., Wang D. Z. M., DiNicolantonio R., Alcorn D., Campbell D. J., Skinner S. L., Renin-containing muller cells of the retina display endocrine features. Investigative Ophthalmology and Visual Science 1995 36 7 1450 1458 2-s2.0-0028988892
87. Brandt C. R., Pumfery A. M., Micales B., Bindley C. D., Lyons G. E., Sramek S. J., Wallow I. H. L., Renin mRNA is synthesized locally in rat ocular tissues. Current Eye Research 1994 13 10 755 763 2-s2.0-0028062107 (Pubitemid 24315082)
88. Satofuka S., Ichihara A., Nagai N., Yamashiro K., Koto T., Shinoda H., Noda K., Ozawa Y., Inoue M., Tsubota K., Suzuki F., Oike Y., Ishida S., Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin. Investigative Ophthalmology & Visual Science 2006 47 6 2686 2692 2-s2.0-33745674108 10.1167/iovs.05-1458
89. Wilkinson-Berka J. L., Heine R., Tan G., Cooper M. E., Hatzopoulos K. M., Fletcher E. L., Binger K. J., Campbell D. J., Miller A. G., RILLKKMPSV Influences the vasculature, neurons and glia, and (Pro)renin receptor expression in the Retina. Hypertension 2010 55 6 1454 1460 2-s2.0-77952933119 10.1161/HYPERTENSIONAHA.109.148221
90. Sramek S. J., Wallow I. H. L., Tewksbury D. A., Brandt C. R., Poulsen G. L., An ocular renin-angiotensin system: immunohistochemistry of angiotensinogen. Investigative Ophthalmology and Visual Science 1992 33 5 1627 1632 2-s2.0-0026594454
91. Gerhardinger C., Costa M. B., Coulombe M. C., Toth I., Hoehn T., Grosu P., Expression of acute-phase response proteins in retinal Muller cells in diabetes. Investigative Ophthalmology and Visual Science 2005 46 1 349 357 10.1167/iovs.04-0860 (Pubitemid 40041218)
92. Wagner J., Danser A. H. J., Derkx F. H. M., De Jong P. T. V. M., Paul M., Mullins J. J., Schalekamp M. A. D. H., Ganten D., Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system. British Journal of Ophthalmology 1996 80 2 159 163 2-s2.0-0030040965 (Pubitemid 26058551)
93. Igic R., Kojovic V., Angiotensin I converting enzyme (kininase II) in ocular tissues. Experimental Eye Research 1980 30 3 299 303 2-s2.0-0018837141 (Pubitemid 10134761)
94. Ferrari-Dileo G., Ryan J. W., Rockwood E. J., Davis E. B., Anderson D. R., Angiotensin-converting enzyme in bovine, feline, and human ocular tissues. Investigative Ophthalmology and Visual Science 1988 29 6 876 881 2-s2.0-0023886586
95. Savaskan E., Löffler K. U., Meier F., Müller-Spahn F., Flammer J., Meyer P., Immunohistochemical localization of angiotensin-converting enzyme, angiotensin II and AT1 receptor in human ocular tissues. Ophthalmic Research 2004 36 6 312 320 2-s2.0-11244316280 10.1159/000081633 (Pubitemid 40069656)
96. Kida T., Ikeda T., Nishimura M., Sugiyama T., Imamura Y., Sotozono C., Nishida K., Kinoshita S., Yoshimura M., Nakamura K., Inokuchi N., Renin-angiotensin system in proliferative diabetic retinopathy and its gene expression in cultured human Müller cells. Japanese Journal of Ophthalmology 2003 47 1 36 41 2-s2.0-0037262685 10.1016/S0021-5155(02)00624-X (Pubitemid 36173868)
97. Danser A. H. J., Derkx F. H. M., Admiraal P. J. J., Deinum J., De Jong P. T. V. M., Schalekamp M. A. D. H., Angiotensin levels in the eye. Investigative Ophthalmology and Visual Science 1994 35 3 1008 1018 2-s2.0-0028359257 (Pubitemid 24079832)
98. Datum K. H., Zrenner E., Angiotensin-like immunoreactive cells in the chicken retina. Experimental Eye Research 1991 53 2 157 165 2-s2.0-0025894761 10.1016/0014-4835(91)90069-Q
99. Mallorga P., Babilon R. W., Sugrue M. F., Angiotensin II receptors labelled with 125I-[Sar1,Ile8]-AII in albino rabbit ocular tissues. Current Eye Research 1989 8 8 841 849 2-s2.0-0024391430 (Pubitemid 19195728)
100. Senanayake P. D., Drazba J., Shadrach K., Milsted A., Rungger-Brandle E., Nishiyama K., Miura S.-I., Karnik S., Sears J. E., Hollyfield J. G., Angiotensin II and its receptor subtypes in the human retina. Investigative Ophthalmology and Visual Science 2007 48 7 3301 3311 10.1167/iovs.06-1024 (Pubitemid 351261177)
101. Sun C., Li H., Leng L., Raizada M. K., Bucala R., Sumners C., Macrophage migration inhibitory factor: an intracellular inhibitor of angiotensin II-induced increases in neuronal activity. Journal of Neuroscience 2004 24 44 9944 9952 2-s2.0-7744235386 10.1523/JNEUROSCI.2856-04.2004 (Pubitemid 39463575)
102. Li D. P., Chen S. R., Pan H. L., Angiotensin II stimulates spinally projecting paraventricular neurons through presynaptic disinhibition. Journal of Neuroscience 2003 23 12 5041 5049 2-s2.0-0038452698
103. Guenther E., Schmid S., Hewig B., Kohler K., Two-fold effect of angiotensin II on voltage-dependent calcium currents in rat retinal ganglion cells. Brain Research 1996 718 1-2 112 116 2-s2.0-0029903162 10.1016/0006-8993(96)00077-7 (Pubitemid 26168733)
104. Demant E., Nagahara K., Niemeyer G., Effects of changes in systemic blood pressure on the electroretinogram of the cat: evidence for retinal autoregulation. Investigative Ophthalmology and Visual Science 1982 23 5 683 687 (Pubitemid 13236109)
105. Jacobi P. C., Osswald H., Jurklies B., Zrenner E., Neuromodulatory effects of the renin-angiotensin system on the cat electroretinogram. Investigative Ophthalmology and Visual Science 1994 35 3 973 980 (Pubitemid 24079828)
106. Jurklies B., Eckstein A., Jacobi P., Kohler K., Risler T., Zrenner E., The renin-angiotensin system-a possible neuromodulator in the human retina? German journal of ophthalmology 1995 4 3 144 150 2-s2.0-0029301189
107. Hashizume K., Mashima Y., Fumayama T., Ohtake Y., Kimura I., Yoshida K., Ishikawa K., Yasuda N., Fujimaki T., Asaoka R., Koga T., Kanamoto T., Fukuchi T., Miyaki K., Genetic polymorphisms in the angiotensin II receptor gene and their association with open-angle glaucoma in a Japanese population. Investigative Ophthalmology and Visual Science 2005 46 6 1993 2001 10.1167/iovs.04-1100
108. Liu Y.-P., Kuznetsova T., Thijs L., Jin Y., Schmitz B., Brand S.-M., Brand E., Manunta P., Bianchi G., Struijker-Boudier H., Staessen J. A., Are retinal microvascular phenotypes associated with the 1675G/A polymorphism in the angiotensin II Type-2 receptor gene. American Journal of Hypertension 2011 24 12 1300 1305 10.1038/ajh.2011.151
109. Yuki K., Ozawa Y., Yoshida T., Kurihara T., Hirasawa M., Ozeki N., Shiba D., Noda K., Ishida S., Tsubota K., Retinal ganglion cell loss in superoxide dismutase 1 deficiency. Investigative Ophthalmology & Visual Science 2011 52 7 4143 4150
110. Imamura Y., Noda S., Hashizume K., Shinoda K., Yamaguchi M., Uchiyama S., Shimizu T., Mizushima Y., Shirasawa T., Tsubota K., Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proceedings of the National Academy of Sciences of the United States of America 2006 103 30 11282 11287 2-s2.0-33746628449 10.1073/pnas.0602131103 (Pubitemid 44156510)
111. Aiello L. P., Avery R. L., Arrigg P. G., Keyt B. A., Jampel H. D., Shah S. T., Pasquale L. R., Thieme H., Iwamoto M. A., Park J. E., Nguyen H. V., Aiello L. M., Ferrara N., King G. L., Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. New England Journal of Medicine 1994 331 22 1480 1487 2-s2.0-0027942607 10.1056/NEJM199412013312203 (Pubitemid 24356306)
112. Gragoudas E. S., Adamis A. P., Cunningham E. T., Feinsod M., Guyer D. R., Pegaptanib for neovascular age-related macular degeneration. New England Journal of Medicine 2004 351 27 2805 2816 2-s2.0-11144239923 10.1056/NEJMoa042760 (Pubitemid 40051904)
113. Rosenfeld P. J., Brown D. M., Heier J. S., Boyer D. S., Kaiser P. K., Chung C. Y., Kim R. Y., Ranibizumab for neovascular age-related macular degeneration. New England Journal of Medicine 2006 355 14 1419 1431 2-s2.0-33749445317 10.1056/NEJMoa054481 (Pubitemid 44511557)
114. Ishida S., Usui T., Yamashiro K., Kaji Y., Ahmed E., Carrasquillo K. G., Amano S., Hida T., Oguchi Y., Adamis A. P., VEGF164 is proinflammatory in the diabetic retina. Investigative Ophthalmology and Visual Science 2003 44 5 2155 2162 10.1167/iovs.02-0807 (Pubitemid 36520312)
115. Ishida S., Usui T., Yamashiro K., Kaji Y., Amano S., Ogura Y., Hida T., Oguchi Y., Ambati J., Miller J. W., Gragoudas E. S., Ng Y. S., D'Amore P. A., Shima D. T., Adamis A. P., VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. Journal of Experimental Medicine 2003 198 3 483 489 2-s2.0-0043125643 10.1084/jem.20022027 (Pubitemid 36976059)
116. Ishida S., Yamashiro K., Usui T., Kaji Y., Ogura Y., Hida T., Honda Y., Oguchi Y., Adamis A. P., Leukocytes mediate retinal vascular remodeling during development and vaso-obliteration in disease. Nature Medicine 2003 9 6 781 788 2-s2.0-0037902889 10.1038/nm877 (Pubitemid 36749230)
117. Otani A., Takagi H., Suzuma K., Honda Y., Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells. Circulation Research 1998 82 5 619 628 2-s2.0-0032559771 (Pubitemid 28129033)
118. Otani A., Takagi H., Oh H., Koyama S., Honda Y., Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells. Diabetes 2001 50 4 867 875 2-s2.0-0035088071 (Pubitemid 32242646)
119. Otani A., Takagi H., Oh H., Suzuma K., Matsumura M., Ikeda E., Honda Y., Angiotensin II-stimulated vascular endothelial growth factor expression in bovine retinal pericytes. Investigative Ophthalmology and Visual Science 2000 41 5 1192 1199 (Pubitemid 30187560)
120. Smith L. E.H., Wesolowski E., McLellan A., Kostyk S. K., D'Amato R., Sullivan R., D'Amore P. A., Oxygen-induced retinopathy in the mouse. Investigative Ophthalmology and Visual Science 1994 35 1 101 111 (Pubitemid 24046832)
121. Alon T., Hemo I., Itin A., Pe'er J., Stone J., Keshet E., Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Medicine 1995 1 10 1024 1028 2-s2.0-0028803509
122. Moravski C. J., Kelly D. J., Cooper M. E., Gilbert R. E., Bertram J. F., Shahinfar S., Skinner S. L., Wilkinson-Berka J. L., Retinal neovascularization is prevented by blockade of the renin-angiotensin system. Hypertension 2000 36 6 1099 1104 2-s2.0-0033664864
123. Lonchampt M., Pennel L., Duhault J., Hyperoxia/normoxia-driven retinal angiogenesis in mice: a role for angiotensin II. Investigative Ophthalmology and Visual Science 2001 42 2 429 432 (Pubitemid 32121475)
124. Satofuka S., Ichihara A., Nagai N., Koto T., Shinoda H., Noda K., Ozawa Y., Inoue M., Tsubota K., Itoh H., Oike Y., Ishida S., Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization. Investigative Ophthalmology and Visual Science 2007 48 1 422 429 10.1167/iovs.06-0534 (Pubitemid 47251433)
125. Funatsu H., Yamashita H., Ikeda T., Nakanishi Y., Kitano S., Hori S., Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders. American Journal of Ophthalmology 2002 133 4 537 543 2-s2.0-0036207489 10.1016/S0002-9394(02)01323-5 (Pubitemid 34258063)
126. Funatsu H., Yamashita H., Nakanishi Y., Hori S., Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy. British Journal of Ophthalmology 2002 86 3 311 315 2-s2.0-0036194229 10.1136/bjo.86.3.311 (Pubitemid 34206346)
127. Senger D. R., Galli S. J., Dvorak A. M., Perruzzi C. A., Susan Harvey V., Dvorak H. F., Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983 219 4587 983 985 2-s2.0-0021111648
128. Larsen M., Hommel E., Parving H. H., Lund-Andersen H., Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy. Graefe's Archive for Clinical and Experimental Ophthalmology 1990 228 6 505 509 2-s2.0-0025087033 (Pubitemid 20362507)
129. Van Kooij B., Fijnheer R., De Boer J., Ten Dam-Van Loon N., Bartelink I., Roest M., Rothova A., A randomized, masked, cross-over trial of lisinopril for inflammatory macular edema. American Journal of Ophthalmology 2006 141 4 646 651 2-s2.0-33645308286 10.1016/j.ajo.2005.11.056
130. Knudsen S. T., Bek T., Poulsen P. L., Hove M. N., Rehling M., Mogensen C. E., Effects of losartan on diabetic maculopathy in type 2 diabetic patients: a randomized, double-masked study. Journal of Internal Medicine 2003 254 2 147 158 2-s2.0-0041842758 10.1046/j.1365-2796.2003.01192.x (Pubitemid 36900438)
131. Kim J. H., Kim J. H., Yu Y. S., Cho C. S., Kim K.-W., Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy. Journal of Cerebral Blood Flow and Metabolism 2009 29 3 621 628 10.1038/jcbfm.2008.154
132. Phipps J. A., Clermont A. C., Sinha S., Chilcote T. J., Bursell S. E., Feener E. P., Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability. Hypertension 2009 53 2 175 181 2-s2.0-59849102068 10.1161/HYPERTENSIONAHA.108.117663
133. Nakamura H., Yamazaki M., Ohyama T., Inoue T., Arakawa N., Domon Y., Yokoyama T., Role of angiotensin II type 1 receptor on retinal vascular leakage in a rat oxygen-induced retinopathy model. Ophthalmic Research 2009 41 4 210 215 2-s2.0-65649120479 10.1159/000217725
134. Chaturvedi N., Sjolie A. K., Stephenson J. M., Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID study group. EURODIAB controlled trial of lisinopril in insulin-dependent diabetes mellitus. The Lancet 1998 351 9095 28 31
135. Shirao Y., Kawasaki K., Electrical responses from diabetic retina. Progress in Retinal and Eye Research 1998 17 1 59 76 2-s2.0-0031964349 10.1016/S1350-9462(97)00005-0 (Pubitemid 28040753)
136. Barber A. J., Lieth E., Khin S. A., Antonetti D. A., Buchanan A. G., Gardner T. W., Neural apoptosis in the retina during experimental and human diabetes: early onset and effect of insulin. Journal of Clinical Investigation 1998 102 4 783 791 2-s2.0-0032529103 (Pubitemid 28399611)
137. +-ATPase activity in the retina of streptozotocin- induced diabetic rats. Investigative Ophthalmology and Visual Science 1996 37 8 1633 1641 (Pubitemid 26271415)
138. Gilbert R. E., Kelly D. J., Cox A. J., Wilkinson-Berka J. L., Rumble J. R., Osicka T., Panagiotopoulos S., Lee V., Hendrich E. C., Jerums G., Cooper M. E., Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes. Diabetologia 2000 43 11 1360 1367 2-s2.0-0033753370 10.1007/s001250051539
139. Zhang J. Z., Xi X., Gao L., Kern T. S., Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy. Current Eye Research 2007 32 10 883 889 2-s2.0-35648935544 10.1080/02713680701584123 (Pubitemid 350034786)
140. Zheng Z., Chen H., Ke G., Fan Y., Zou H., Sun X., Gu Q., Xu N., Ho P. C. P., Protective effect of perindopril on diabetic retinopathy is associated with decreased vascular endothelial growth factor-to-pigment epithelium-derived factor ratio: involvement of a mitochondria-reactive oxygen species pathway. Diabetes 2009 58 4 954 964 2-s2.0-64649091717 10.2337/db07-1524
141. Yamagishi S. I., Takeuchi M., Matsui T., Nakamura K., Imaizumi T., Inoue H., Angiotensin II augments advanced glycation end product-induced pericyte apoptosis through RAGE overexpression. FEBS Letters 2005 579 20 4265 4270 2-s2.0-23644432209 10.1016/j.febslet.2005.06.058 (Pubitemid 41116350)
142. Satofuka S., Ichihara A., Nagai N., Noda K., Ozawa Y., Fukamizu A., Tsubota K., Itoh H., Oike Y., Ishida S., (Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation. Diabetes 2009 58 7 1625 1633 2-s2.0-67650236573 10.2337/db08-0254
143. Mullins J. J., Peters J., Ganten D., Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 1990 344 6266 541 544 2-s2.0-0025239301 10.1038/344541a0 (Pubitemid 20124430)
144. Moravski C. J., Skinner S. L., Stubbs A. J., Sarlos S., Kelly D. J., Cooper M. E., Gilbert R. E., Wilkinson-Berka J. L., The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studies. American Journal of Pathology 2003 162 1 151 160 2-s2.0-0037220601 (Pubitemid 36041997)
145. Dosso A. A., Rungger-Brändle E., Leuenberger P. M., Ultrastructural alterations in capillaries of the diabetic hypertensive rat retina: protective effects of ACE inhibition. Diabetologia 2004 47 7 1196 1201 2-s2.0-4143135497 (Pubitemid 39093316)
146. Miller A. G., Tan G., Binger K. J., Pickering R. J., Thomas M. C., Nagaraj R. H., Cooper M. E., Wilkinson-Berka J. L., Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function. Diabetes 2010 59 12 3208 3215 2-s2.0-78650044928 10.2337/db10-0552
147. Chen P., Guo A. M., Edwards P. A., Trick G., Scicli A. G., Role of NADPH oxidase and ANG II in diabetes-induced retinal leukostasis. American Journal of PhysiologyRegulatory Integrative and Comparative Physiology 2007 293 4 R1619 R1629 10.1152/ajpregu.00290.2007 (Pubitemid 47535780)
148. Zhang J. Z., Gao L., Widness M., Xi X., Kern T. S., Captopril inhibits glucose accumulation in retinal cells in diabetes. Investigative Ophthalmology and Visual Science 2003 44 9 4001 4005 10.1167/iovs.02-1193 (Pubitemid 37047975)
149. Zhang X., Lassila M., Cooper M. E., Cao Z., Retinal Expression of Vascular Endothelial Growth Factor Is Mediated by Angiotensin Type 1 and Type 2 Receptors. Hypertension 2004 43 2 276 281 2-s2.0-0842332569 10.1161/01.HYP. 0000113628.94574.0f (Pubitemid 38174187)
150. Sakurai E., Anand A., Ambati B. K., Van Rooijen N., Ambati J., Macrophage depletion inhibits experimental choroidal neovascularization. Investigative Ophthalmology and Visual Science 2003 44 8 3578 3585 10.1167/iovs.03-0097 (Pubitemid 36909798)
151. Tsutsumi C., Sonoda K. H., Egashira K., Qiao H., Hisatomi T., Nakao S., Ishibashi M., Charo I. F., Sakamoto T., Murata T., Ishibashi T., The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization. Journal of Leukocyte Biology 2003 74 1 25 32 2-s2.0-0042069977 10.1189/jlb.0902436 (Pubitemid 38040433)
152. Espinosa-Heidmann D. G., Suner I. J., Hernandez E. P., Monroy D., Csaky K. G., Cousins S. W., Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Investigative Ophthalmology and Visual Science 2003 44 8 3586 3592 10.1167/iovs.03-0038 (Pubitemid 36909799)
153. Nagai N., Oike Y., Izumi-Nagai K., Koto T., Satofuka S., Shinoda H., Noda K., Ozawa Y., Inoue M., Tsubota K., Ishida S., Suppression of choroidal neovascularization hy inhibiting angiotensin-converting enzyme: minimal role of bradykinin. Investigative Ophthalmology and Visual Science 2007 48 5 2321 2326 10.1167/iovs.06-1296 (Pubitemid 351261312)
154. Satofuka S., Ichihara A., Nagai N., Noda K., Ozawa Y., Fukamizu A., Tsubota K., Itoh H., Oike Y., Ishida S., (Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system. American Journal of Pathology 2008 173 6 1911 1918 2-s2.0-57149089446 10.2353/ajpath.2008.080457
155. Striker G. E., Praddaude F., Alcazar O., Cousins S. W., Marin-Castaño M. E., Regulation of angiotensin II receptors and extracellular matrix turnover in human retinal pigment epithelium: role of angiotensin II. American Journal of Physiology 2008 295 6 C1633 C1646 2-s2.0-57349092212 10.1152/ajpcell.00092.2008
156. Praddaude F., Cousins S. W., Pêcher C., Marin-Castaño M. E., Angiotensin II-induced hypertension regulates AT1 receptor subtypes and extracellular matrix turnover in mouse retinal pigment epithelium. Experimental Eye Research 2009 89 1 109 118 2-s2.0-67349098413 10.1016/j.exer.2009.02.020
157. Alcazar O., Cousins S. W., Striker G. E., Marin-Castano M. E., (Pro)renin receptor is expressed in human retinal pigment epithelium and participates in extracellular matrix remodeling. Experimental Eye Research 2009 89 5 638 647 2-s2.0-70349448532 10.1016/j.exer.2009.06.014
158. Pons M., Cousins S. W., Alcazar O., Striker G. E., Marin-Castano M. E., Angiotensin II-induced MMP-2 activity and MMP-14 and basigin protein expression are mediated via the angiotensin ii receptor type 1-mitogen-activated protein kinase 1 pathway in retinal pigment epithelium: implications for age-related macular degeneration. American Journal of Pathology 2011 178 6 2665 2681 10.1016/j.ajpath.2011.02.006
159. Wheeler-Schilling T. H., Kohler K., Sautter M., Guenther E., Angiotensin II receptor subtype gene expression and cellular localization in the retina and non-neuronal ocular tissues of the rat. European Journal of Neuroscience 1999 11 10 3387 3394 2-s2.0-0032824992 10.1046/j.1460-9568.1999.00787.x (Pubitemid 29484235)
160. Cullinane A. B., Leung P. S., Ortego J., Coca-Prados M., Harvey B. J., Renin-angiotensin system expression and secretory function in cultured human ciliary body non-pigmented epithelium. British Journal of Ophthalmology 2002 86 6 676 683 2-s2.0-0036286671 10.1136/bjo.86.6.676 (Pubitemid 34627960)
161. Costagliola C., Di Benedetto R., De Caprio L., Verde R., Mastropasqua L., Effect of oral captopril (SQ 14225) on intraocular pressure in man. European Journal of Ophthalmology 1995 5 1 19 25 2-s2.0-0028935048
162. Costagliola C., Verolino M., Leonarda De Rosa M., Iaccarino G., Ciancaglini M., Mastropasqua L., Effect of oral losartan potassium administration on intraocular pressure in normotensive and glaucomatous human subjects. Experimental Eye Research 2000 71 2 167 171 2-s2.0-0033829316 10.1006/exer.2000.0866
163. Wang R. F., Podos S. M., Mittag T. W., Yokoyoma T., Effect of CS-088, an angiotensin AT1 receptor antagonist, on intraocular pressure in glaucomatous monkey eyes. Experimental Eye Research 2005 80 5 629 632 2-s2.0-17944404930 10.1016/j.exer.2004.11.012 (Pubitemid 40602963)
164. Shah G. B., Sharma S., Mehta A. A., Goyal R. K., Oculohypotensive effect of angiotensin-converting enzyme inhibitors in acute and chronic models of glaucoma. Journal of Cardiovascular Pharmacology 2000 36 2 169 175 10.1097/00005344-200000006-00001
165. Constad W. H., Fiore P., Samson C., Cinotti A. A., Use of an angiotensin converting enzyme inhibitor in ocular hypertension and primary open-angle glaucoma. American Journal of Ophthalmology 1988 105 6 674 677 2-s2.0-0023895495
166. Platten M., Youssef S., Eun M. H., Ho P. P., Han M. H., Lanz T. V., Phillips L. K., Goldstein M. J., Bhat R., Raine C. S., Sobel R. A., Steinman L., Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proceedings of the National Academy of Sciences of the United States of America 2009 106 35 14948 14953 2-s2.0-70349267599 10.1073/pnas.0903958106
167. Lanz T. V., Ding Z., Ho P. P., Luo J., Agrawal A. N., Srinagesh H., Axtell R., Zhang H., Platten M., Wyss-Coray T., Steinman L., Angiotensin II sustains brain inflammation in mice via TGF- β Journal of Clinical Investigation 2010 120 8 2782 2794 10.1172/JCI41709
168. Ito T., Yamakawa H., Bregonzio C., Terron J. A., Falcon-Neri A., Saavedra J. M., Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist. Stroke 2002 33 9 2297 2303 10.1161/01.STR.0000027274.03779.F3 (Pubitemid 35014646)
169. Chen S., Li G., Zhang W., Wang J., Sigmund C. D., Olson J. E., Chen Y., Ischemia-induced brain damage is enhanced in human renin and angiotensinogen double-transgenic mice. American Journal of PhysiologyRegulatory Integrative and Comparative Physiology 2009 297 5 R1526 R1531 10.1152/ajpregu.91040.2008
170. Yamakawa H., Jezova M., Ando H., Saavedra J. M., Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition. Journal of Cerebral Blood Flow and Metabolism 2003 23 3 371 380 (Pubitemid 36307581)
171. Fleegal-Demotta M. A., Doghu S., Banks W. A., Angiotensin II modulates BBB permeability via activation of the AT 1 receptor in brain endothelial cells. Journal of Cerebral Blood Flow and Metabolism 2009 29 3 640 647 10.1038/jcbfm.2008.158
172. Millan M. A., Jacobowitz D. M., Aguilera G., Catt K. J., Differential distribution of AT1 and AT2 angiotensin II receptor subtypes in the rat brain during development. Proceedings of the National Academy of Sciences of the United States of America 1991 88 24 11440 11444 2-s2.0-0026357448 (Pubitemid 21916057)
173. Lucius R., Gallinat S., Rosenstiel P., Herdegen T., Sievers J., Unger T., The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats. Journal of Experimental Medicine 1998 188 4 661 670 2-s2.0-0032541392 10.1084/jem.188.4.661 (Pubitemid 28387929)
174. Iwai M., Liu H. W., Chen R., Ide A., Okamoto S., Hata R., Sakanaka M., Shiuchi T., Horiuchi M., Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation. Circulation 2004 110 7 843 848 2-s2.0-4143095706 10.1161/01.CIR.0000138848.58269.80 (Pubitemid 39096013)
175. Unger T., The role of the renin-angiotensin system in the development of cardiovascular disease. American Journal of Cardiology 2002 89 supplement 2A 3A 10A (Pubitemid 34143240)
176. Armando I., Carranza A., Nishimura Y., Hoe K. L., Barontini M., Terrón J. A., Falcón-Neri A., Ito T., Juorio A. V., Saavedra J. M., Peripheral administration of an angiotensin II AT1 receptor antagonist decreases the hypothalamic-pituitary-adrenal response to isolation stress. Endocrinology 2001 142 9 3880 3889 2-s2.0-17944363903 10.1210/en.142.9.3880 (Pubitemid 32802660)
177. Okuyama S., Sakagawa T., Sugiyama F., Fukamizu A., Murakami K., Reduction of depressive-like behavior in mice lacking angiotensinogen. Neuroscience Letters 1999 261 3 167 170 2-s2.0-0033582638 10.1016/S0304-3940(99)00002-6 (Pubitemid 29104971)
178. Shekhar A., Johnson P. L., Sajdyk T. J., Fitz S. D., Keim S. R., Kelley P. E., Gehlert D. R., DiMicco J. A., Angiotensin-II is a putative neurotransmitter in lactate-induced panic-like responses in rats with disruption of GABAergic inhibition in the dorsomedial hypothalamus. Journal of Neuroscience 2006 26 36 9205 9215 2-s2.0-33748478373 10.1523/JNEUROSCI.2491-06. 2006 (Pubitemid 44359847)
179. Zhu D., Shi J., Zhang Y., Wang B., Liu W., Chen Z., Tong Q., Central angiotensin II stimulation promotes β amyloid production in Sprague Dawley rats. PLoS ONE 2011 6 1 e16037 10.1371/journal.pone.0016037
180. Wang J., Ho L., Chen L., Zhao Z., Zao W., Qian X., Valsartan lowers brain β -amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. Hipertension 2008 25 2 85 86 10.1016/S0212-8241(08)70878-8 (Pubitemid 351457434)
181. Zou K., Yamaguchi H., Akatsu H., Angiotensin-converting enzyme converts amyloid β -protein 142 (A β (142)) to A β (140), and its inhibition enhances brain A β deposition. The Journal of Neuroscience 2007 27 32 8628 8635 (Pubitemid 47254272)
182. Shaw S., Bencherif M., Marrero M. B., Angiotensin II Blocks Nicotine-Mediated Neuroprotection against β -Amyloid (1-42) via Activation of the Tyrosine Phosphatase SHP-1. Journal of Neuroscience 2003 23 35 11224 11228 2-s2.0-0346749449 (Pubitemid 37548958)
183. Bui B. V., Armitage J. A., Tolcos M., Cooper M. E., Vingrys A. J., ACE inhibition salvages the visual loss caused by diabetes. Diabetologia 2003 46 3 401 408 2-s2.0-0038303104 (Pubitemid 36547596)
184. Phipps J. A., Wilkinson-Berka J. L., Fletcher E. L., Retinal dysfunction in diabetic ren-2 rats is ameliorated by treatment with valsartan but not atenolol. Investigative Ophthalmology and Visual Science 2007 48 2 927 934 10.1167/iovs.06-0892 (Pubitemid 351260731)
185. Ozawa Y., Nakao K., Kurihara T., Shimazaki T., Shimmura S., Ishida S., Yoshimura A., Tsubota K., Okano H., Roles of STAT3/SOCS3 pathway in regulating the visual function and ubiquitin-proteasome-dependent degradation of rhodopsin during retinal inflammation. Journal of Biological Chemistry 2008 283 36 24561 24570 2-s2.0-54049099260 10.1074/jbc.M802238200
186. Ozawa Y., Nakao K., Shimazaki T., Shimmura S., Kurihara T., Ishida S., Yoshimura A., Tsubota K., Okano H., SOCS3 is required to temporally fine-tune photoreceptor cell differentiation. Developmental Biology 2007 303 2 591 600 2-s2.0-33847364312 10.1016/j.ydbio.2006.11.032 (Pubitemid 46341283)
187. Ozawa Y., Nakao K., Shimazaki T., Takeda J., Akira S., Ishihara K., Hirano T., Oguchi Y., Okano H., Downregulation of STAT3 activation is required for presumptive rod photoreceptor cells to differentiate in the postnatal retina. Molecular and Cellular Neuroscience 2004 26 2 258 270 2-s2.0-2942665721 10.1016/j.mcn.2004.02.001 (Pubitemid 38781083)
188. Ozawa Y., Kurihara T., Tsubota K., Okano H., Regulation of posttranscriptional modification as a possible therapeutic approach for retinal neuroprotection. Journal of Ophthalmology 2011 2011 8 506137 10.1155/2011/506137
189. Miyoshi M., Miyano K., Moriyama N., Taniguchi M., Watanabe T., Angiotensin type 1 receptor antagonist inhibits lipopolysaccharide-induced stimulation of rat microglial cells by suppressing nuclear factor κ B and activator protein-1 activation. European Journal of Neuroscience 2008 27 2 343 351 2-s2.0-38349094462 10.1111/j.1460-9568.2007.06014.x
190. Benicky J., Sanchez-Lemus E., Pavel J., Saavedra J. M., Anti-inflammatory effects of angiotensin receptor blockers in the brain and the periphery. Cellular and Molecular Neurobiology 2009 29 6-7 781 792 10.1007/s10571-009-9368- 4
191. Song M. R., Ghosh A., FGF2-induced chromatin remodeling regulates CNTF-mediated gene expression and astrocyte differentiation. Nature Neuroscience 2004 7 3 229 235 2-s2.0-1442299902 10.1038/nn1192 (Pubitemid 38280446)
192. Downie L. E., Pianta M. J., Vingrys A. J., Wilkinson-Berka J. L., Fletcher E. L., AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen-induced retinopathy. GLIA 2008 56 10 1076 1090 2-s2.0-51349130208 10.1002/glia.20680
193. Okada S., Nakamura M., Katoh H., Miyao T., Shimazaki T., Ishii K., Yamane J., Yoshimura A., Iwamoto Y., Toyama Y., Okano H., Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nature Medicine 2006 12 7 829 834 2-s2.0-33745919498 10.1038/nm1425 (Pubitemid 44050074)
194. Buchi E. R., Cell death in the rat retina after a pressure-induced ischaemia-reperfusion insult:an electron microscopic study. I. Ganglion cell layer and inner nuclear layer. Experimental Eye Research 1992 55 4 605 613 2-s2.0-0026483301 10.1016/S0014-4835(05)80173-3
195. Berkelaar M., Clarke D. B., Wang Y. C., Bray G. M., Aguayo A. J., Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. Journal of Neuroscience 1994 14 7 4368 4374 2-s2.0-0028310855 (Pubitemid 24200558)
196. Li Y., Schlamp C. L., Nickells R. W., Experimental induction of retinal ganglion cell death in adult mice. Investigative Ophthalmology and Visual Science 1999 40 5 1004 1008 (Pubitemid 29153269)
197. Takami S., Imai Y., Katsuya T., Ohkubo T., Tsuji I., Nagai K., Satoh H., Hisamichi S., Higaki J., Ogihara T., Gene polymorphism of the renin-angiotensin system associates with risk for lacunar infarction: the Ohasama study. American Journal of Hypertension 2000 13 2 121 127 2-s2.0-17344393902 10.1016/S0895-7061(99)00184-3 (Pubitemid 30125633)
198. Hata J., Matsuda K., Ninomiya T., Yonemoto K., Matsushita T., Ohnishi Y., Saito S., Kitazono T., Ibayashi S., Iida M., Kiyohara Y., Nakamura Y., Kubo M., Functional SNP in an Sp1-binding site of AGTRL1 gene is associated with susceptibility to brain infarction. Human Molecular Genetics 2007 16 6 630 639 2-s2.0-34247116957 10.1093/hmg/ddm005 (Pubitemid 46585664)
199. Henskens L. H. G., Kroon A. A., Van Boxtel M. P. J., Hofman P. A. M., De Leeuw P. W., Associations of the angiotensin II type 1 receptor A1166C and the endothelial NO synthase G894T gene polymorphisms with silent subcortical white matter lesions in essential hypertension. Stroke 2005 36 9 1869 1873 2-s2.0-24644515339 10.1161/01.STR.0000177867.39769.cb (Pubitemid 41266516)
200. Wilkinson-Berka J.L. Tan G. Binger K.J. Sutton L. McMaster K. Deliyanti D. Perera G. Campbell D.J.Miller A.G. Aliskiren reduces vascular pathology in diabetic retinopathy and oxygen-induced retinopathy in the transgenic (mRen-2)27 rat Diabetologia 2011 54 10 2724-2735 10.1007/s00125-011-2239-9